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Summary In this paper, a combined analysis was performed to study the interaction between familial risk and reproductive life factors. In
particular, the interaction between familial risk and breast cell mitotic activity (BCMA), as assessed by duration of ovarian activity, was
investigated because of the potential importance of mitotic activity on genetically susceptible cells. The present analysis included 3152 cases
and 4404 controls in seven case-control studies from four countries. The interaction effect was estimated in each study separately, then
combined using two different methods: a multivariate weighted average and a Bayesian random-effects model. The main effects of
reproductive life factors on the risk of breast cancer were in agreement with the previous findings. In particular, an increased duration of
BCMA before the first childbirth and over life was found to increase the risk of breast cancer (P < 0.001). Slightly increasing but non-
significant, familial risks were observed with increasing numberof children (P= 0.17), increasing age atfirst childbirth (P> 0.2) and increasing
duration of BCMA (P > 0.2). There was no modification in familial risk with age at menarche and no clear pattern with menopause
characteristics. A weak influence of reproductive and menstrual factors on the familial risk emerged from the present study.
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The association of a family history of breast cancer with an
increased risk of breast cancer has been well documented. This
risk increases with the number of affected relatives and a
decreasing degree of kinship (Kelsey and Horm-Ross, 1993).
Segregation analyses of large population-based family studies
have shown that familial aggregation of breast cancer can be
explained by the transmission ofa dominant gene with a high life-
time penetrance (Williams and Anderson, 1984; Newman et al,
1988; Claus et al, 1991; Iselius et al, 1991). Linkage analyses of
multiple breast and breast-ovarian cancer families led to the local-
ization of two breast cancer genes accounting for a minority of
cases (5-10%) (Hall et al; 1990; Narod et al, 1991; Wooster et al,
1994). However, more complex mechanisms have also been
suggested, and several family studies have indicated a possible
genetic heterogeneity for breast cancer (Demenais et al, 1986;
Gilligan and Borecki, 1986; Andrieu et al, 1988; Goldstein et al,
1988; Goldstein and Amos, 1990).
Genetic factors do not explain all of the variation in breast
cancer rates. In particular, several reproductive factors are well-
established risk factors for breast cancer. These include an early
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age at menarche, a late age at menopause, a late age at first child-
birth and nulliparity. The risks associated with other reproductive
factors such as abortions, certain characteristics of the menstrual
cycle, infertility and breast feeding are still controversial (Kelsey
and Horm-Ross, 1993). Overall relative risks associated with
reproductive factors are typically about 2.0 or less and even if
oestrogen activity seems involved in breast cancer occurrence, the
mechanisms underlying such effects are still obscure. In fact,
except for the general observation that longer exposure to
menstrual activity brings about an increased risk for breast cancer,
no generally accepted mechanisms have been proposed to explain
these epidemiological characteristics.
The difficulty in detecting relevant factors and understanding
their role in the aetiology ofbreast cancer may be due to the use of
inaccurate measures of oestrogen activity or to heterogeneity in
susceptibility of the population of cases studied. For example,
several studies have found that some reproductive factors might
have a variable effect on the occurrence ofbreast cancer according
to the existence or not of a family history ofbreast cancer (Adami
et al, 1980; Bain et al, 1980; Brinton et al, 1982; Sattin et al, 1985;
Olsson et al, 1985; Richardson et al, 1985; Dupont and Page,
1987; Negri et al, 1988; Malone and Daling, 1992; Parazzini et al,
1992; Sellers et al, 1992; 1993; Andrieu et al, 1993; 1995; Colditz
et al, 1993; 1996). In a previous study we investigated the exis-
tence of an interaction between familial risk of breast cancer and
abortion by combining six case-control studies from various
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Table 1 Studies included in the combined analysis
Study Country Number of Number of Age at interview Year of interview
cases controls (years)
Rohan et al (1988) Australia 451 451 20-74 1982-1984
Lee et al (1991) Singapore 200 420 24-88 1986-1988
Lifanova et al (unpublished data) Russia 885 1068 21-87 1992-1994
Richardson et al (1991) France 450 603 21-66 1983-1987
Luporsi (1988) France 406 812 24-83 1985-1987
Le et al (1984) France 265 265 22-46 1982-1984
Clavel et al (1991) France 495 785 20-56 1983-1987
Total 3152 4404
countries. Our findings suggested a synergism between familial
factors and abortion (Andrieu et al, 1995). In this paper, the
combined analysis is extended to study the existence ofan interac-
tion between familial risk and otherreproductive factors. In partic-
ular, the interaction between familial risk and breast cell mitotic
activity (BCMA) as assessed by ovarian activity is investigated
because of the potential importance of mitotic activity on geneti-
cally susceptible cells. The investigation combines the six
case-control studies previously analysed and a seventh from
Singapore. The aim ofthe present study was to investigate how the
effect of family history is modified by reproductive factors. In
addition, the risk associated with reproductive factors were exam-
ined in the two groups defined by the presence or absence of a
family history ofbreast cancer.
MATERIALS AND METHODS
The analysis included case-control studies from four countries,
France, Australia, Russia and Singapore. The data sets were
chosen because they had information on family history of breast
cancer and as well as reproductive factors of interest, such as age
at menarche, number ofchildren, number ofabortions, age at first
childbirth, menopausal status and age at menopause. For all
studies, family history of breast cancer was recalled by the
subjects and was not verified from medical records. The present
analysis included 3152 cases and 4404 controls. No family history,
in this analysis, includes unknown family history. Most studies in
the combined analysis have been published. The seven studies are
briefly described in Table 1, and the main design features are
presented below.
In a case-control study from South Australia (Rohan et al, 1988)
the cases were obtained from the population-based South
Australian Central Cancer Registry between 1982 and 1984 to
investigate the relationship between dietary intake and the risk of
breast cancer. Cases were between 20 and 74 years of age, with a
histologically verified first diagnosis of breast cancer. For each
case, one control was selected at random from the electoral roll
from among women of approximately the same age as that of the
case at diagnosis. Study subjects were interviewed in their homes
by trained interviewers. In addition to information on usual dietary
intake, information on family history of cancer in sisters, mother
and grandmothers was recorded. Forthe present study, information
about first-degree relatives only was provided (Rohan et al, 1988).
In a case-control study from Singapore (Lee et al, 1992), breast
cancer patients were consecutive admissions to Singapore General
Hospital and the National University Hospital between 1986 and
1988. About twice as many controls as cases were selected within
5-year age groups. Subjects were between 24 and 88 years ofage.
They were interviewed in hospital by experienced investigators. In
addition to information on dietary intake, the interview also
included questions about reproductive life factors and history of
breast cancer in the subject's mother, sisters or maternal aunts.
Data were obtained from a case-control study performed in
Moscow (Russia) (Lifanova et al, unpublished) that focused on
diet, alcohol consumption and reproductive factors. Subjects were
interviewed from 1992 to 1994. Cases were aged between 23 and
82 years old with histologically confirmed primary carcinoma of
the breast and were recruited from four Moscow hospitals.
Controls were women with minor non-chronic complaints regis-
tered in primary care polyclinics in Moscow. Information was
recorded on the occurrence ofbreast cancer in the family (sisters,
mother, aunts and grandmothers).
A case-control study carried out in Montpellier (France)
(Richardson et al, 1991) focused on nutritional factors. Subjects
were interviewed between 1983 and 1987. Cases were women
aged between 26 and 66 years old with histologically confirmed
primary carcinoma of the breast who were hospitalized in the
Montpellier Cancer Institute and had not previously undergone
any therapy. Controls were women ofthe same age range admitted
for the first time into three different wards: neurology, neuro-
surgery and general surgery. These women were attending for a
first diagnosis and hence were not being currently treated for
chronic diseases. Information was recorded on the occurrence of
breast cancer in the family (sisters, mother and aunts) and the
number ofsisters and aunts.
A case-control study carried out in Nancy Cancer Institute
(France) between 1985 and 1987 (Luporsi, 1988) investigated the
relationship between familial factors, alcohol, tobacco and obesity
and the risk ofbreast cancer. Cases were between 24 and 83 years
of age, with a histologically confirmed infiltrating breast carci-
noma. Controls were women admitted into general surgery or
general medicine wards. These women were examined to elimi-
nate a diagnosis ofcancer. Controls were matched to cases by age
at interview (± 3 years), residential area and occupational status.
Each case was matched to two controls. Information was recorded
on the occurrence of breast cancer in the family (sisters, mother,
aunts and grandmothers) and the number ofsisters and aunts.
A multicentre case-control study performed in France between
1981 and 1984 (Le et al, 1984) investigated the relationship
between oral contraceptive use and the risk ofbreast cancer. Cases
were between 20 and 45 years ofage, with ahistologically verified
breast carcinoma diagnosed less than a year before the interview.
Each case was matched with one control with respect to hospital,
date of interview and age. This control was chosen from patients
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with non-malignant diseases, excluding benign breast disease and
severe or moderate cervical dysplasia. Information was recorded
on the occurrence of breast cancer in the family (sisters, mother,
aunts and grandmothers) and the number ofsisters and aunts.
Data were obtained from a case-control study in five French
hospitals between 1983 and 1987 (Clavel et al, 1991) that investi-
gated the relationship between oral contraceptive use and the risk
ofbreast cancer. Cases were between 20 and 56 years ofage. They
had a histologically confirmed infiltrating or in situ breast carci-
noma. Three types ofcontrols were eligible for each case: friends,
colleagues or patients hospitalized for a non-malignant disease.
The criteria for matching controls to cases were the centre, age at
interview (± 5 years) and year of interview (± 14 months). Each
case and her matching controls were interviewed by the same
interviewer. The 111 controls with a malignant disease were
excluded from the present analysis and the matching broken.
Information was recorded on the occurrence ofbreast cancerin the
family (sisters, mother, aunts and grandmothers) and the number
of sisters and aunts.
Statistical methods
In the first stage of the analysis, each study was analysed sepa-
rately using unconditional logistic regression for the unmatched
studies and conditional logistic regression for the matched studies.
For each study, in order to examine interactions of family history
with reproductive life variables, the risk of a family history of
breast cancer was calculated separately in each stratum of the
reproductive life factors. To test the interaction, a chi-square test
for heterogeneity was performed by comparing the difference
between the deviance of the above model and that of a model in
which the familial risk was assumed to be the same in all
strata. The risks of reproductive life factors were calculated for
each subgroup: with or without family history of breast cancer.
These analyses were performed using the software package
EGRET.
Two different combined analyses were performed. The first one
was performed using a classical approach in which the relative
risks estimated using logistic regression were combined by taking
a multivariate weighted average (WM). This method allows the
point and interval estimates of relative risks to be obtained and
provides tests of the effects on risk and of heterogeneity from
study to study. Mathematical details are given elsewhere (Ewertz
et al, 1990; Woolf, 1955). The interaction was tested as the statis-
tical significance of the weighted average of the interaction terms
using a 0.05 level ofsignificance.
In the second analysis, the combined relative risks were esti-
mated using a Bayesian random-effects model. A random-effects
analysis assumes that the true effects in each study are not neces-
sarily equal, but are random pertubations about some common
mean effect. Inferences based on this model were obtained by the
simulation technique known as Gibbs sampling (GS) (Gelfand and
Smith, 1990). This model allows for between study heterogeneity
in effects and hence gives wider 95% confidence intervals on the
combined effects when heterogeneity is present.
The variables studied are age at menarche, age at first childbirth,
number of children, age at menopause, and estimations of the
duration ofBCMA. Among nulliparous women, BCMA until first
childbirth (pre-first-childbirth BCMA) was calculated by totalling
the years between menarche and interview for premenopausal
women or menopause for post-menopausal women. Among
parous women, pre-first-childbirth BCMA was calculated as the
years between menarche and first childbirth. The pre-first-child-
birth BCMA was categorized into four classes [< 10 years, (11-15
years), (16-20 years), 2 21 years]. The lifetime BCMA was calcu-
lated by totalling the years ofreproductive life between menarche
and interview for premenopausal women, or menopause for post-
menopausal women, and then subtracting the estimated total years
offull-term pregnancy, which is the number ofchildren multiplied
by 0.75 (0.75 years = average length of pregnancy). Lifetime
BCMA is equal to pre-first-childbirth BCMA in nulliparous
women. Then lifetime BCMA was categorized in four classes
[< 28 years, (28-32 years), (33-37 years), 2 38 years]. Because
detailed information on incomplete pregnancies was not available
for most studies, a precise assessment ofBCMA was not possible.
However, analyses were performed adjusting for total number of
abortions (both spontaneous and induced) for six out
of the seven studies (number of abortions not available for the
Lee et al study).
RESULTS
Main effects of reproductive factors
First, the main effects of reproductive life factors were investi-
gated. In three ofthe seven studies, a significant decrease in risk of
breast cancer was found for women with an age at menarche of
more than 15 years compared with those with an age at menarche
less than 13 years (Richardson et al, Le et al, Clavel et al) (data not
shown). In the other four, although the odds ratio associated with
an age at menarche of more than 15 years are not significantly
different from unity, the point estimates were all less than one. The
combined analysis confirmed this observation with an odds ratio
of 0.75 (95% CI 0.65-0.87) with WM, and 0.73 (95% CI
0.61-0.87) with GS (Table 2). A significant trend of decreasing
risk with increasing age at menarche is found in two ofthe studies
(Clavel et al, Le et al) and in the WM combined analysis.
In all the studies, a decrease in risk of breast cancer was found
for women with three or more children. However, in only two
studies is this risk significantly different from unity (Lee et al,
Clavel et al). The two methods forcombining data lead to identical
point estimates ofodds ratios: 0.89 (95% CI 0.77-1.03 with WM,
95% CI 0.76-1.05 with GS) associated with one or two children,
0.71 (95% CI 0.60-0.83 with WM, 95% CI 0.60-0.86 with GS)
associated with three or more children (Table 2). A trend of
decreasing risk with increasing number ofchildren is significant in
three ofthe studies (Lee et al, Luporsi, Clavel et al) and in the WM
combined analysis.
In only two out of the seven studies was a significantly
decreased risk ofbreast cancer found for women aged 24 years or
less at first childbirth (Lee et al, Lifanova et al) compared with
nulliparous women. In five out of the seven studies, an increased
risk of breast cancer was observed with increasing age at first
child among parous women. In only three studies (Lee et al,
Lifanova et al, Luporsi) is the trend found to be significant (data
not shown). The combined analyses confirmed a significantly
decreased risk of breast cancer with an age at first childbirth of
less than 24 years [0.81 (95% CI 0.69-0.95) with WM, 0.80 (95%
CI 0.67-0.96) with GS] and an increasing risk of breast cancer
with increasing age at first childbirth among parous women (with
WM, P trend = 0.002) (Table 2).
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Table 2 Combined odds ratios of breast cancer associated with age at menarche, age at first childbirth, number
of children and age at menopause
Reproductive factors OR 95 %CI Pt
Age at menarche
Fixed effect (Woolf)
< 12 years 1a
(13-14) 0.96 (0.86-1.08)
2 15 years 0.75 (0.65-0.87) <0.001
Random effect (Gibbs sampling)
< 12 years la
(13-14) 0.97 (0.83-1.13)
2 15 years 0.73 (0.61-0.87)
Age at first child
Fixed effect (Woolf)
No childbirth 1b
<24 years 0.81 (0.69-0.95)
(25-29) 0.92 (0.78-1.09) 0.002
.30 years 1.10 (0.90-1.34)
Random effect (Gibbs sampling)
No childbirth 1b
<24 years 0.84 (0.72-1.00)
(25-29) 0.96 (0.81-1.14)
.30 years 1.10 (0.89-1.35)
Number of children
Fixed effect (Woolf)
no child ic
1-2 0.89 (0.77-1.03)
.3 0.71 (0.60-0.83) <0.001
Random effect (Gibbs sampling)
No child jc
1-2 0.89 (0.76-1.05)
.3 0.71 (0.60-0.86)
Age at menopause
Fixed effect (Woolf)
Premenopausal 1d
Menopausal < 50 years 0.62 (0.52-0.74)
Menopausal . 50 years 0.93e (0.93-1.12)
Random effect (Gibbs sampling)
Premenopausal 1d
Menopausal <50 years 0.61 (0.48-0.78)
Menopausal .50 years 0.92 (0.70-1.21)
aAdjusted for age at interview, age at first child, number of abortions (except for Lee et al), number of children,
menopausal status and family history of breast cancer; badjusted for age at interview, number of abortions
(except for Lee et al), age at menarche, number of children, menopausal status and family history of breast
cancer; cadjusted for age at interview, age at first child, number of abortions (except for Lee et al), age at
menarche, menopausal status and family history of breast cancer; dadjusted for age at interview, age at first
child, number of abortions (except for Lee et al), number of children, age at menarche and family history of
breast cancer; eodds ratio estimated on six data sets (Le et al excluded).
In all the studies, a decreased risk of breast cancer was found
associated with menopause, especially when menopause
occurred before 50 years of age (data not shown). However,
being menopausal before 50 years of age is associated with a
significant decreased risk of breast cancer in only four of the
studies (Richardson et al, Luporsi, Le et al, Clavel et al). The
two methods for combining data lead to similar point estimates
of odds ratios for women who were menopausal before 50 years
of age: 0.62 (95% CI 0.52-0.74) with WM, and 0.61 (95% CI
0.48-0.78) with GS, and for women who were menopausal after
50 years of age (OR = 0.93 with WM; OR = 0.92 with GS)
(Table 2). Effects of artificial and natural menopause are very
similar and lie between the point estimates for menopause at
age less than 50 and menopause at age greater than 50 (data
not shown).
The main effectofpre-first-childbirth BCMA is shown inTable 3.
In only two of the seven studies, a clear trend of increased risk of
breast cancer with increasing duration of pre-first-childbirth
BCMA was found (Lee et al, Lifanova et al). Nevertheless,
combined analyses led to a significant increased risk of breast
cancerassociated with an increased duration ofpre-first-childbirth
BCMA (P trend in WM is less than 0.001).
In all studies, an increased risk ofbreast cancer was associated
with an increased lifetime BCMA (Table 4). Moreover, an
increasing trend is significant (P < 0.05) in five ofthe studies (Lee
et al, Lifanova et al, Richardson et al, Luporsi, Clavel et al) and in
the combined analysis.
For both pre-first-childbirth BCMA and lifetime BCMA, confi-
dence intervals and point estimates of odds ratios from the two
methods for combined analyses are similar.
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Table 3 Risk of breast cancer associated with duration of pre-first-childbirth BCMA
Study OR" 95%CI Pt
Rohan et al (1988)
< 10 years
(11-15)
(16-20)
> 21 years
Lee et al (1991)
c 10 years
(11-15)
(16-20)
2 21 years
Lifanova et al (unpublished data)
. 10 years
(11-15)
(16-20)
2 21 years
Richardson et al (1991)
< 10 years
(11-15)
(16-20)
> 21 years
Luporsi (1988)
< 10 years
(11-15)
(16-20)
2 21 years
Le et al (1984)
< 10 years
(11-15)
(16-20)
2 21 years
Clavel et al (1991)
< 10 years
(11-15)
(16-20)
. 21 years
Combined analysis
Fixed effect (Woolf)
< 10 years
(11-15)
(16-20)
> 21 years
Random effect (Gibbs sampling)
< 10 years
(11-15)
(16-20)
. 21 years
1.10
0.94
1.11
1.52
1.54
7.16
1.50
1.68
1.72
1.51
0.89
1.19
0.99
1.69
1.08
1.00
0.89
1.22
1.17
1.86
1.30
1.25
1.35
1.40
(0.80-1.51)
(0.61-1.45)
(0.71-1.73)
(0.97-2.37)
(0.87-2.74)
(3.27-15.7)
(1.17-1.94)
(1.18-2.38)
(1.25-2.37)
(1.12-2.05)
(0.56-1.42)
(0.79-1.77)
(0.74-1.34)
(1.09-2.62)
(0.73-1.59)
(0.63-1.58)
(0.49-1.61)
(0.68-2.20)
(0.89-1.53)
(1.26-2.75)
(0.89-1.89)
(1.11-1.40)
(1.14-1.60)
(1.20-1.65)
1.23
1.33
1.45
n.s.
<0.001
<0.001
0.034
0.087
n.s.
0.019
<0.001
(1.03-1.50)
(1.06-1.66)
(1.17-1.82)
aAdjusted for age at interview, number of abortions (except for Lee et al), number of children,
menopausal status and family history of breast cancer; Pt, P-value for trend.
Variation of familial risk according to reproductive
factors
The main effect of family history was investigated. The effect
was significant in all studies [Rohan et al, 1.6 (95% CI 1.0-2.7);
Lee et al, 3.1 (95% CI 1.3-7.2); Lifanova et al, 4.1 (95% CI
2.6-6.7); Richardson et al, 2.8 (95% CI 1.7-4.6); Luporsi, 2.7
(95% CI 1.9-3.9); Le et al, 1.9 (95% CI 1.2-3.0); Clavel et al, 1.5
(95% CI 1.1-2.0)]. The odds ratio associated with a family
history estimated from the combined analysis was 2.2 (95%
CI 1.9-2.6).
In Tables 5-7 results for the effect of reproductive life factors
stratified by family history of breast cancer and for the effect of a
family history stratified by different levels of the reproductive life
factors are presented. These tables can be readin twodifferent ways,
depending on whether one is interested in the modifications of the
familial risk because ofreproductive life factors orby the modifica-
tions ofthe risk from reproductive life factors because of a familial
factor. None ofthe tests ofheterogeneity ofeffects between studies
were statistically significant; nor were any ofthe tests forinteraction
offamily history with reproductive life variables statistically signi-
ficant, either within individual studies or in the combined analyses.
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Table 4 Risk of breast cancer associated with duration of lifetime BCMA
Study ORa 95%CI Pt
Rohan et al (1988)
< 27 years
(28-32)
(33-37)
< 38 years
Lee et al (1991)
< 27 years
(28-32)
(33-37)
.38 years
Lifanova et al (unpublished data)
< 27 years
(28-32)
(33-37)
.38 years
Richardson et al (1991)
< 27 years
(28-32)
(33-37)
.38 years
Luporsi (1988)
<27 years
(28-32)
(33-37)
.38 years
Le et al (1984)
< 27 years
(28-32)
(33-37)
.38 years
Clavel et al (1991)
<27 years
(28-32)
(33-37)
.38 years
Combined analysis
Fixed effect (Woolf)
< 27 years
(28-32)
(33-37)
>38 years
Random effect (Gibbs sampling)
< 27 years
(28-32)
(33-37)
.38 years
0.99
1.28
1.61
1.58
2.44
1.97
1.30
1.85
2.25
1.59
2.44
2.80
1.52
2.20
2.36
1.28
1.69
1.64
2.57
2.93
1.40
2.01
2.38
1.30
1.85
2.16
(0.67-1.48)
(0.87-1.89)
(1.02-2.56)
(0.99-2.51)
(1.44 4.16)
(0.89-4.35)
(0.93-1.83)
(1.32-2.60)
(1.48-3.43)
(1.07-2.37)
(1.63-3.64)
(1.72-4.56)
(0.94-2.45)
(1.33-3.64)
(1.36-4.12)
(0.68-2.38)
(0.43-6.56)
(1.03-2.61)
(1.59-4.17)
(1.74-4.93)
(1.20-1.63)
(1.71-2.38)
(1.93-2.94)
0.106
0.012
< 0.001
< 0.001
< 0.001
n.s.
< 0.001
< 0.001
(1.12-1.51)
(1.58-2.18)
(1.77-2.65)
aAdjusted for age at interview, number of abortions (except for Lee et al), age at first child and family
history of breast cancer.
The point estimate of the odds ratio associated with a family
history ofbreast cancer is higher for women who were older than
15 years at menarche than for women who were younger than 13
years in four of the seven studies and is lower in the three others
(data not shown). For both methods, the combined analyses illus-
trate this discrepancy leading to similar odds ratios whatever the
age at menarche (Table 5).
The point estimate of the familial risk odds ratio (ORFR)
increases as age at first childbirth increases among parous women
in five of the seven studies (Lifanova et al, Richardson et al,
Luporsi, Lk et al, Clavel et al) (data not shown). Combined
analyses confirmed these observations with an odds ratio of 1.95
for women who were less than 25 years old at theirfirst childbirth,
2.40 for those who were between 25 and 29 years old and 2.80 for
those who were olderthan 25 years, using GS. Thepattern ofOR.
is less clear using WM (Table 6).
In six of the seven studies, the point estimates of ORFR are
higher for women having three or more children than for those
having one or two (Rohan et al, Lee et al, Lifanova et al,
Richardson et al, Luporsi, Clavel et al). Among these six studies,
theOR. point estimates are higher for women who have three or
more children compared with nulliparous women in only three of
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Table 5 Variation of breast cancer risk associated with the age at menarche, age at first childbirth, number of children, age at menopause according to the
presence or not of a family history of breast cancer and variation of familial risk according to the age at menarche, age at first childbirth, number ofchildren, age
at menopause: results of combined analysis.
Without family history of breast cancer With family history of breast cancer Familial risk
Reproductive factors Cases Controls OR 95% Cl Cases Controls OR 95% Cl OR 95% Cl pa
Age at menarcheb
Fixed effect (Woolf)
< 12 years
(13-14)
2 15 years
Unknown
Random effect (Gibbs sampling)
< 12 years
(13-14)
> 15 years
Age at first childbirthc
Fixed effect (Woolf)
No childbirth
< 24 years
(25-29)
.30 years
Unknown
Random effect (Gibbs Sampling)
No childbirth
< 24 years
(25-29)
.30 years
Number of childrenf
Fixed effect (Woolf)
0
(1-2)
.3
Unknown
Random effect (Gibbs Sampling)
0
(1-2)
.3
Age at menopauseh
Fixed effect (Woolf)
Premenopausal
< 50 years
.50 years
Random effect (Gibbs sampling)
Premenopausal
< 50 years
.50 years
832 1172 1 150
1222 1795 0.98 (0.87-1.10) 195
465 872 0.76 (0.65-0.88) 75
9 22 - - 0
832 1172 1 150
1222 1795 0.98 (0.83-1.16) 195
465 872 0.73 (0.59-0.87) 75
390
1155
669
309
5
514 1 60
1969 0.86d (0.73-1.02) 181
995 0.94d (0.79-1.11) 124
368 1.106 (0.85-1.42) 55
14 - - 0
390 514 1
1155 1969 0.83 (0.69-1.00) 60
669 995 0.91 (0.76-1.09) 181
309 368 1.09 (0.87-1.35) 55
390 515 1 60
1431 2011 0.94d (0.80-1.11) 235
707 1330 0.779 (0.63-0.94) 125
0 5 - - 0
390 515 1 60
1431 2011 0.93 (0.77-1.12) 235
707 1330 0.73 (0.60-0.91) 125
1206 1811 1 237
576 1135 0.62 (0.52-0.74) 88
735 900 0.94i (0.77-1.14) 95
1206 1811 1 237
576 1135 0.62 (0.50-0.76) 88
735 900 0.94 (0.73-1.16) 95
100
142
67
0
100
142
67
32
165
87
24
1
32
165
87
32
174
103
0
32
174
103
165
85
59
165
85
59
1 2.22 (1.67-2.94)
0.91 (0.60-1.39) 2.07 (1.13-3.81) n.s.
0.76 (0.44-1.29) 2.22 (1.13-4.34)
1 2.29 (1.61-3.31)
0.93 (0.65-1.35) 2.18 (1.60-3.01)
0.75 (0.47-1.20) 2.25 (1.47-3.41)
1 2.18d (1.33-3.59)
0.69d (0.38-1.28) 1.76d (0.64-4.85)
1.18d (0.55-2.53). 2.74d (0.90-8.35) n.s.
1.07e (0.45-2.55) 1.86e (0.58-6.02)
1 2.74 (1.64-4.75)
0.63 (0.38-1.02) 1.95 (1.41-2.72)
0.83 (0.49-1.36) 2.40 (1.66-3.60)
1.17 (0.60-2.27) 2.80 (1.61-5.08)
1 2.35d (1.44-3.84)
0.78d (0.47-1.32) 1.96d (0.95-4.06) 0.17
0.769 (0.43-1.33) 2.359 (1.69-3.26)
1 2.72 (1.67-4.67)
0.69 (0.42-1.13) 2.01 (1.50-2.67)
0.65 (0.38-1.11) 2.38 (1.66-3.34)
1 2.17 (1.84-2.57)
0.62 (0.42-0.91) 2.16 (1.55-3.01) n.s.
0.87i (0.55-1.38) 2.11 (1.43-3.14)
1 2.41 (1.72-3.64)
0.63 (0.41-0.95) 2.27 (1.45-3.58)
0.91 (0.58-1.42) 2.07 (1.30-3.32)
aTest for interaction; badjusted for age at interview, age at first child, number of abortions (except for Lee et al), number of children, menopausal status;
cadjusted for age at interview, age at menarche, number of abortions (except for Lee et al), number of children, menopausal status; dodds ratios estimated on
six data sets (Lee et al excluded); eodds ratios estimated on five data sets (Richardson et al and Lee et al excluded); 'adjusted for age at interview, age at
menarche, age at first child, number of abortions (except for Lee et al), menopausal status; godds ratios estimated on five data sets (Lifanova et al and Lee et al
excluded); hadjusted for age at interview, age at menarche, number of abortions (except for Lee et al), number of children, age at first child; 'odds ratios
estimated on six data sets (Le et al excluded).
the six (Lifanova et al, Luporsi, Clavel et al) (data not shown). after 50 years old. This decreasing risk is more noticeable using
Combined analyses led to similarobservations with aORFR of 1.96 GS with an odds ratio of2.41 for premenopausal women, 2.27 for
with WM and 2.01 with GS for women with one or two children women menopausal before 50 years old and 2.07 for women
and of 2.35 with WM and 2.38 with GS for women with three or menopausal after 50 years old (Table 5).
more children (Table 5). The variation of the familial risk according to pre-first-child-
The patternofvariation in familial risk according to menopausal birth BCMA differs from study to study and subsequently the
status and age at menopause differs from study to study. A signifi- combined analyses lead to an unclear pattern of the familial risk
cant interaction is found in Lifanova and colleague's study (Table 6).
(P = 0.04) (data not shown). However, the combined analyses The pattern of variation in familial risk according to lifetime
show a decrease in familial risk from premenopausal women, to BCMA differs from study to study (Table 7). However in five of
women menopausal before 50 years old, to women menopausal the seven studies, the point estimates of the odds ratio associated
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Table 6 Variation of breast cancer risk and of familial risk associated with duration of pre-first-childbirth BCMA according to the presence or not of a family
history of breast cancer and variation of familial risk according to duration of pre-first childbirth BCMA
Without family history of breast cancer With family history of breast cancer familial risk
Study Cases Controls ORa 95% Cl Cases Controls OR' 95% Cl OR' 95% Cl pb
Rohan et al (1988)
< 10 years
(11-15)
(16-20)
> 21 years
Unknown
Lee et al (1991)
< 10 years
(11-15)
(16-20)
>21 years
Unknown
Lifanova et al (unpublished data)
< 10 years
(11-15)
(16-20)
> 21 years
Richardson et al (1991)
< 10 years
(11-15)
(16-20)
> 21 years
Unknown
Luporsi (1988)
< 10 years
(11-15)
(16-20)
> 21 years
Le et al (1984)
< 10 years
(11-15)
(16-20)
>21 years
Clavel et al (1991)
< 10 years
(11-15)
(16-20)
21 years
Combined analysis
Fixed effect (Woolf)
10 years
(11-15)
(16-20)
21 years
Unknown
153 167 1 13
131 135 1.09 (0.79-1.52) 15
52 57 0.94 (0.60-1.48) 5
66 61 1.08 (0.68-1.70) 8
8 4 - - 0
77 233 1 2
54 103 1.54 (0.98-2.41) 3
276 14 1.44 (0.79-2.61)
2 8 - 0
232 398 1 25
180 211 1.51 (1.16-1.96) 28
76 86 1.65 (1.15-2.36) 9
119 115 1.72 (1.24-2.39) 12
171 283 1 21
125 138 1.43 (1.04-1.95) 16
33 59 0.79 (0.49-1.28) 6
66 82 1.11 (0.73-1.67) 7
5 12 - - 0
144 362 1 31
90 209 1.04 (0.75-1.43) 25
37 57 1.55 (0.94-2.41) 11
56 114 1.09 (0.72-1.64) 12
90 102 1 26
54 64 0.95 (0.58-1.57) 20
24 31 0.84 (0.45-1.60) 6
34 30 1.16 (0.62-2.17) 11
144 301 1 34
132 230 1.19 (0.88-1.60) 40
57 58 2.00 (1.31-3.08) 14
63 85 1.41 (0.94-2.11) 11
1011 1846 1 152
766 1090 1.26 (1.11-1.42) 147
305 400 1.32 (1.10-1.57) 56
431 501 1.32c (1.11-1.56) 65
15 24 - 0
10 1 1.50 (0.64-3.55)
10 1.12 (0.35-3.56) 1.54 (0.66-3.60)
4 0.92 (0.19-4.35) 1.46 (0.37-5.77) n.s.
3 1.71 (0.35-8.30) 2.39 (0.60-9.48)
0 - -
4 1 1.82 (0.32-10.3)
4 1.29 (0.13-12.82) 1.52 (0.32-7.14)
0
2 4.06 (0.37-43.98) 5.12 (0.93-28.3)
- -
11 1 4.00 (1.92-8.30)
9 1.44 (0.51-4.06) 3.82 (1.75-8.33)
1 3.07 (0.34-27.8) 7.43 (0.90-61.2) n.s.
3 1.69 (0.39-7.26) 3.91 (1.07-14.3)
20 1 1.79 (0.93-3.42)
5 3.09 (0.93-10.2) 3.86 (1.35-11.1)
1 5.45 (0.59-50.1) 12.30 (1.40-108) n.s.
2 3.06 (0.56-16.8) 4.90 (0.98-24.8)
1 -
31 1 2.68 (1.56-4.61)
27 0.80 (0.38-1.70) 2.07 (1.13-3.79)
2 5.17 (1.05-25.5) 9.23 (1.92-44.3) n.s.
10 1.00 (0.37-2.72) 2.48 (1.00-6.14)
19 1 1.63 (0.83-3.21)
11 1.24 (0.47-3.30) 2.13 (0.92-4.91)
4 1.13 (0.29-4.48) 2.19 (0.53-8.95) n.s.
4 1.52 (0.40-5.76) 2.15 (0.63-7.30)
41 1 1.79 (1.08-2.96)
44 1.05 (0.56-1.97) 1.58 (0.97-2.56)
12 1.30 (0.53-9.23) 1.16 (0.49-2.75) n.s.
14 0.81 (0.32-2.06) 1.03 (0.44-2.44)
136 1 2.14 (1.66-2.75)
110 1.17 (0.82-1.65) 1.98 (1.49-2.64) n.s.
26 1.62 (0.94-2.78) 2.62 (1.56-4.41)
36 1.32c (0.80-2.19) 2.11c (1.34-3.33)
1 -
Random effect (Gibbs sampling)
< 10 years 1011 1846 1 152
(11-15) 766 1090 1.25 (1.05-1.47) 147
(16-20) 305 400 1.30 (1.05-1.60) 56
.21 years 431 501 1.44 (1.18-1.79) 65
136 1 2.09 (1.55-2.81)
110 1.22 (0.85-1.76) 2.05 (1.51-2.83)
26 1.90 (1.13-3.30) 3.03 (1.82-5.20)
36 1.53 (0.95-2.51) 2.27 (1.44-3.71)
British Journal of Cancer (1998) 77(9), 1525-1536
aAdjusted for age at interview, number of abortions (except for Lee et al), number of children, menopausal status; btest for interaction; codds ratios estimated on
six data sets (Lee et al excluded).
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Table 7 Variation of breast cancer risk associated with duration of lifetime BCMA according to the presence or not of a family history of breast cancer and
variation of familial risk according to duration of lifetime BCMA
Without family history of breast cancer With family history of breast cancer Familial risk
Study Cases Controls ORa 95% Cl Cases Controls ORa 95% Cl ORa 95% Cl pb
Rohan et al (1988)
< 27 years
(28-32)
(33-37)
2 38 years
Unknown
Lee et al (1991)
< 27 years
(28-32)
(33-37)
> 38 years
Unknown
Lifanova et al (unpublished data)
< 27 years
(28-32)
(33-37)
38 years
Unknown
Richardson et al (1991)
<27 years
(28-32)
(33-37)
>38 years
Unknown
Luporsi (1988)
<27 years
(28-32)
(33-37)
38 years
Le et al (1984)
< 27 years
(28-32)
(33-37)
>38 years
Clavel et al (1991)
< 27 years
(28-32)
(33-37)
38 years
Combined analysis
Fixed effect (Woolf)
<27 years
(28-32)
(33-37)
.38 years
Unknown
Random effect (Gibbs sampling)
< 27 years
(28-32)
(33-37)
.38 years
99
85
134
78
14
54
61
51
15
2
85
144
268
110
0
69
88
149
92
2
57
66
127
77
136
60
6
0
138
97
132
29
639
617
852
402
18
639
617
852
402
111 1
109 0.96 (0.63-1.45)
133 1.28 (0.85-1.91)
64 1.58 (0.98-2.55)
7 -
9
10
13
9
0
8
6
9
4
0
1.57
1.38
2.12
162 1 4 5 1
133 1.56 (0.98-2.49) 4 2 2.85
24 } 2.30 (1.39-3.83) 1 3.46
6 - - 0 0 -
188 1
235 1.32 (0.93-1.87)
289 1.92 (1.36-2.72)
95 2.33 (1 .52-3.58)
3 - _
180 1
135 1.65 (1.09-2.50)
158 2.36 (1.56-3.59)
83 2.67 (1.61-4.43)
18 - -
195 1
155 1.84 (1.10-3.00)
250 2.52 (1.53-4.15)
142 3.01 (1.75-5.18)
156 1
66
} 1.44 (0.65-3.19)
0 -
288 1
185 1.46 (1.01-2.10)
170 2.05 (1.32-3.19)
31 2.94 (1 .51-5.72)
1268 1
1035 1.38 (1.18-1.62)
1084 1.94c (1.63-2.31)
441 2.14d (1.72-2.66)
33 - -
1268 1
1035 1.29 (1.10-1.50)
1084 1.80 (1.52-2.11)
441 2.12 (1.72-2.60)
14
21
27
12
0
14
9
14
13
0
16
14
32
17
40
23
0
0
36
42
11
11
132
106
121
61
0
132
106
121
61
5
7
9
3
0
14
10
3
2
0
15
24
20
11
1
1.06
0.95
1.20
1
0.97
4.45
6.08
1
0.84
2.52
2.10
26 1
0 }
0
44
43
13
11
130
87
62
30
0
130
87
62
30
2.08
3.86
3.13
1.58
2.79c
2.53d
1.39
2.48
2.57
(0.39-6.37)
(0.38-4.98)
(0.46-9.81)
(0.31-25.60)
(0.49-24.50)
(0.28-4.08)
(0.26-3.45)
(0.23-6.28)
(0.29-3.19)
(1.03-19.2)
(1.13-32.8)
(0.29-2.42)
(0.89-7.11)
(0.66-6.67)
1.32 (0.49-3.58)
2.16 (0.75-6.22)
1.42 (0.59-3.45) n.s.
1.77 (0.52-6.05)
2.06 (0.52-8.23)
3.76 (0.65-21.7)
3.10 (0.74-13.1)
n.s.
6.30 (2.19-18.1)
5.07 (2.10-12.3)
3.12 (1.44-6.80) n.s.
3.24 (0.87-12.0)
2.71 (1.22-6.01)
1.60 (0.61-4.19)
5.11 (1.44-18.2) n.s.
6.17 (1.35-28.3)
3.57 (1.58-8.06)
1.63 (0.77-3.46)
3.57 (1.84-6.92) n.s.
2.49 (1.07-5.76)
1.85 (1.06-3.21)
(0.57-4.46) 2.60 (1.08-6.23) n.s.
(1.01-4.27)
(1.77-8.42)
(1.07-9.10)
(1.05-2.37)
(1.78-4.38)
(1.44-4.44)
(0.94-2.04)
(1.63-3.71)
(1.56-4.36)
1.18 (0.70-1.87)
1.68 (0.92-3.05)
2.21 (1.18-4.14) n.s.
1.25 (0.45-3.50)
1.89 (1.44-2.48)
2.16 (1.57-2.96) n.s.
2.72c (2.00-3.91)
2.21 d (1 .36-3.59)
2.03 (1.50-2.88)
2.12 (1.51-3.04)
2.71 (1.84-4.03)
2.38 (1.44-4.02)
British Journal ofCancer(1998) 77(9), 1525-1536
aAdjusted for age at interview, number of abortions (except for Lee et al), age at first child; btest for interaction; codds ratios estimated on six data sets (Le et al
excluded); dodds ratios estimated on five data sets (Le et al and Lee et al excluded).
0 Cancer Research Campaign 19981534 NAndrieu etal
with lifetime BCMA are higher for women with a family history
of breast cancer compared with women without. Consequently,
combined analyses lead to an increasing familial risk as lifetime
BCMA increases except in the last category in which a slight
decrease is observed. For duration of BCMA less than 28 years,
between 28 and 32 years, between 33 and 37 years and greater
than 37 years, ORFR = 1.89, 2.16, 2.72 and 2.21 with WM and
2.03, 2.12, 2.71 and 2.38 with GS respectively.
DISCUSSION
The findings ofthis study with regard to the effects ofreproductive
life factors on the risk of breast cancer are in agreement with
previous studies (Kelsey and Horm-Ross, 1993). An increased risk
of breast cancer was found to be associated with an early age at
menarche, a late age at first childbirth, nulliparity, premenopausal
status and increasing durations of both pre-first-childbirth BCMA
and lifetime BCMA. Results were consistent from study to study
and risk factors seemed similar wherever the studies were
conducted.
Exposure to menstrual activity has been used as a surrogate for
assessing BCMA, which is mainly controlled by oestrogens. In
assessing BCMA before first childbirth and over the entire repro-
ductive life, we did not account for periods of oral contraceptive
use. However, this may not lead to inaccurate measurement
because an increase in BCMA has been found in the later weeks of
the oral contraceptive cycle. Indeed, results of two studies
suggested that total BCMA may be very similar over an oral
contraceptive cycle and a normal cycle (Pike et al, 1993).
The accuracy of the measurement we have used to assess
BCMA could, however, still be challenged and the overall cumula-
tive number of menstrual cycles may be a better measurement.
Indeed, experimental evidence indicates that BCMA is maximal in
the luteal phase of the cycle (Anderson et al, 1982; Ferguson and
Anderson, 1982). Moreover, the luteal phase appears to be less
variable than the follicular phase, leading to women with short
cycles spending relatively more time in the luteal phase and conse-
quently in mitotic activity, than do women with longer cycles.
However, menstrual cycle length was not available in most studies
and even ifit was, retrospective reports ofmenstrual bleeding have
been shown to be unreliable (Whelan et al, 1994).
Lifetime BCMA showed a higher increase in risk than pre-first-
childbirth BCMA. Moreover, this effect is consistent across
studies with similar point estimates of odds ratios, and higher
values for longer exposure making BCMA a relevant risk factor.
When interactions were investigated, a slight increasing familial
risk was observed with an increasing number of children
(P = 0.17), an increasing age at first childbirth (P> 0.20) and an
increasing lifetime BCMA (P > 0.2). However, none of these
interactions was significant. No modification in familial risk was
found with age at menarche, and there was also no clear pattern
with pre-first-childbirth BCMA nor menopause characteristics.
Some studies have investigated variations in familial risk
according to reproductive factors, whereas other studies have
investigated variations in reproductive risk factors according to
familial factors. The tests performed to detect variations in risks
were similar whichever ofthese two approaches was used. We have
chosen to present and comment on results such as the effect of a
family history stratified by reproductive factors as we were inter-
ested in the modifications of the familial risk due to reproductive
factors. No interaction between familial factor and reproductive
factors was significant, but it is possible that this is due to lack of
power to detect interactions even with large sample sizes.
The two methods used to perform the combined analyses led to
similar results in which data were complete. Moreover none ofthe
tests of heterogeneity of effects between studies were not signifi-
cant. From these two observations, we conclude that there are not
important residual differences among the study results. The GS
method allowed blank categories to contribute information to the
estimation of the combined effects, whereas in the WM method
such data cannot be used. This led to small differences in some of
the estimates and confidence intervals.
The measurement of a family history of breast cancer was not
homogeneous from study to study. Four studies recorded informa-
tion in first- and second-degree relatives (Le et al, 1984; Clavel
et al, 1991; Luporsi, 1988; Lifanova, unpublished). Two studies
recorded information in first- and second-degree relatives but not
in grandmothers (Richardson et al, 1991; Lee et al, 1992) and one
study recorded information in first-degree relatives only (Rohan et
al, 1988). The heterogeneity in definition of family history could
substantially explain the observed difference in familial risk esti-
mates from study to study. This difference affects the precision of
the combined familial risk estimate leading to a decrease in power
for detecting a variation in this riskby reproductive factors. Thus,
the risk estimated from the combined analyses measured the
familial risk of breast cancer without a precise definition of the
familial relationship. The heterogeneity in the method of
measuring family history might have induced errors in the interac-
tion estimations if genetic susceptibility differs according to type
of familial relationship with an affected relative, and if the
reproductive factors effect differs according to the type ofgenetic
susceptibility. The occurrence of both conditions is necessary for
there to be errors in the estimation ofthe interaction term. Byrne et
al (1991) found that different factors could modify in different
directions the effects of an affected mother and the effects of an
affected sister. However, aside from the fact that type of affected
relatives will probably not define ahomogeneous group ofgenetic
susceptibility, the number of cases in our study was not large
enough to subdivide subjects with afamily history ofbreast cancer
according to the type of affected relatives. Further studies
including a larger number of subjects could investigate the varia-
tion of the interaction according to the type of relationship of
affected relative.
'No family history' in this study included 'unknown family
history'. This could bias the results if cases were more aware of
such a history than controls. In several studies, however, cases and
controls had a similar proportion of relatives with an unknown
cancer status and this proportion is small (among first-degree rela-
tives: Le et al 1.5%; Richardson et al 3%; Clavel et al 2%; Luporsi
3%). Also, although this bias might affect the estimation of the
relative risk for the main effect offamily history, there is no reason
to assume that it would vary according to the reproductive factors.
Familial effects have been described as increasing in younger
women. A difference in familial effects on breast cancer risk
according to the age of subjects could introduce confounding in
the interactions studied, even with adjustment for age, and a three-
dimensional interaction (family history -reproductive factor - age
of subjects) may be needed. However, a recent meta-analysis
showed a breast cancer risk associated with a family history of
breast cancer in first-degree relatives of 1.9 (1.8-2.8) in women
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older than 50 years and of 2.4 (2.2-2.7) in women younger than
50 years (Pharoah et al, 1997). The difference in familial risks did
not appear large. Nevertheless, as before, further studies including
a large number of subjects could investigate the effect ofsubjects'
age on the possible interactions between reproductive life factors
and family history.
Among eight studies that have investigated the variation in breast
cancer risk associated with age at menarche by family history,
three found such a variation, in contrast with our study in which
no difference has been found between groups (Bain et al, 1980;
Brinton et al, 1982; Negri et al, 1988; Malone and Daling, 1992;
Parazzini et al, 1992; Andrieu et al, 1993; Sellers et al, 1993;
Colditz et al, 1996). In previous studies, the variation always
reflected the same trend, namely an increased risk associated with
a late age at menarche for women with a family history of breast
cancer and a decreased risk associated with a late age at menarche
for women without family history (Bain et al, 1980; Parazzini et al,
1992; Malone and Daling, 1992). None of the other studies found
an increased risk associated with a late age at menarche among
women with a family history and they failed to observe a
decreasing risk with late age at menarche such as was observed
among women without a family history (Brinton et al, 1982;
Negri et al, 1988; Andrieu et al, 1993; Sellers et al, 1993; Colditz
et al, 1996).
Seven epidemiological studies have researched an interaction
between parity and family history of breast cancer (Bain et al,
1980; Negri et al, 1988; Parazzini et al, 1992; Sellers et al, 1992;
1993; Colditz et al, 1993; 1996). Four studies out of seven did not
observe a variation in familial riskaccording to numberofchildren
(Bain et al, 1980; Sellers et al, 1992; 1993; Colditz et al, 1993). In
the three others, no protection from multiple births was observed
when compared with nulliparity among women with a family
history of breast cancer (Negri et al, 1988; Parazzini et al, 1992;
Colditz et al, 1996). In the present study, no clear pattern emerges
in the variation of familial risk between nulliparous and parous
women. However, familial risk seems to increase slightly
(P = 0.17) for women with a high parity (three and more children)
compared with women with a low parity (one or two children).
Age at first full-term pregnancy has been studied in eight
published studies. No evident increase in risks according to age at
first childbirth has been found among women with afamily history
of breast cancer in three studies (Negri et al, 1988; Byrne et al,
1991; Colditz et al, 1993). In two others, a similar increase in risk
with age at first childbirth has been observed (Brinton et al, 1982;
Parazzini et al, 1992). In the three remaining studies, in agreement
with the tendency of our finding, an increase in risk has been
described that is stronger among women with a family history than
among women without a family history (Dupont and Page, 1987;
Sellers et al, 1992; Colditz et al, 1996).
Parity and first full-term pregnancy have been suggested to
have antagonistic main effects on breast cells. Indeed, animal
models suggest that their effects are a combination of increased
mitotic activity during the first two trimesters of pregnancy with
the counteracting effect of breast cells differentiation during the
last trimester (Russo and Russo, 1980). If different types of
susceptibility are varyingly sensitive to the antagonistic effects of
full-term pregnancy and parity on breast cells, then one could
partially explain the difficulty in detecting a clear pattern in
familial risk variations and consequently the observed differences
in published studies.
To our knowledge, only two studies have examined interaction
between familial risk and BCMA (Bain et al, 1980; Colditz et al,
1993). These two analyses were performed in the Nurses' Health
Study. The authors used the absolute interval between menarche and
menopause as BCMA. In agreement with the trend of our results,
they showed an increased familial risk among women who menstru-
ated for more than 35 years in the first report, based on prevalent
breast cancercases (Bain etal, 1980), but not in the prospective data
(Colditz etal, 1993). Obviously, longer mitotic activity increases the
probability ofdamaging DNA and ofconverting DNA damage into
mutation, and may have a critical effect on cells predisposed to
become malignant because of inherited mutations. In the present
study, a difference in the increase in risks associated with BCMA
between women with and without a family history ofbreast cancer
is not observed for pre-first-childbirth BCMA but slight difference
was found for lifetime BCMA. This difference appears for BCMA
durations over 28 years. An increased duration ofBCMA might be
associated with a slight increased risk of breast cancer for geneti-
cally susceptible women. Further studies including a very large
number ofcases may verify the existence ofthis plausible effect.
A possible weak influence ofreproductive and menstrual factors
on the familial risk emerges from the present study. Further studies
including larger number of subjects could increase power in
detecting interactions and permit the investigation ofthe variation
of the familial-reproductive factors interactions according to the
type ofrelationship ofaffected relative and the age ofsubjects.
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